Login / Signup

Correction: Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment.

Dotan MoskovichYael FinkelshteinAdi AlfandariAmit RosemarinTzuri LifschytzAvivit WeiszSantanu MondalHarinarayana UngatiAviva KatzavDebora KidronGovindasamy MugeshMartin EllisBernard LererOsnat Ashur-Fabian
Published in: Oncogene (2023)
Keyphrases
  • signaling pathway
  • cancer therapy
  • drug delivery